Nino Bablishvili
Tbilisi, TB, Georgia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Programmatic Diagnostic Accuracy and Clinical Utility of Xpert MTB/XDR in Patients With Rifampicin-Resistant Tuberculosis in Georgia.
Journal: Open forum infectious diseases
Published: October 24, 2024
EFFICACY AND SAFETY OF SILVER NANOCOMPOSITES ON RIFAMPICIN-RESISTANT M. TUBERCULOSIS STRAINS.
Journal: Georgian medical news
Published: September 04, 2024
Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 09, 2023
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: August 02, 2022
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational study.
Journal: The Lancet. Microbe
Published: November 17, 2021
Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections.
Journal: Nature communications
Published: November 05, 2020
Clinical Outcomes Among Patients With Drug-resistant Tuberculosis Receiving Bedaquiline- or Delamanid-Containing Regimens.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 02, 2019
A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.
Journal: The European respiratory journal
Published: August 23, 2017
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
Journal: The Lancet. Infectious diseases
Published: August 14, 2017
Moxifloxacin target site concentrations in patients with pulmonary TB utilizing microdialysis: a clinical pharmacokinetic study.
Journal: The Journal of antimicrobial chemotherapy
Published: June 28, 2017
Last Updated: 09/26/2026